Structures by: Nash R. J.
Total: 19
C33H39NO4S2
C33H39NO4S2
Organic letters (2011) 13, 16 4414-4417
a=10.1866(15)Å b=13.017(2)Å c=22.877(4)Å
α=90.00° β=90.00° γ=90.00°
C33H39NO4S2
C33H39NO4S2
Organic letters (2011) 13, 16 4414-4417
a=8.7786(18)Å b=14.075(3)Å c=24.580(5)Å
α=90.00° β=90.00° γ=90.00°
C30H35NO5
C30H35NO5
Organic letters (2011) 13, 16 4414-4417
a=13.347(4)Å b=5.1520(15)Å c=19.349(6)Å
α=90.00° β=97.644(4)° γ=90.00°
C32H39NO6
C32H39NO6
Organic letters (2011) 13, 16 4414-4417
a=12.634(3)Å b=8.8253(18)Å c=14.418(3)Å
α=90.00° β=115.10(3)° γ=90.00°
Methyl 3,6-anhydro-4-azido-5,7-O-(S)-benzylidene-2,4-dideoxy-D-talo-heptonate
C15H17N3O5
Acta Crystallographica Section E (2004) 60, 5 o839-o840
a=8.2135(3)Å b=9.2262(3)Å c=10.9944(3)Å
α=90° β=108.0414(15)° γ=90°
(1R,2R,3S,6S,7S,7aR)-3-Hydroxymethyl-1,2,6,7- tetrahydroxypyrrolizidine monohydrate or (2S,3R,4R,5R,6S,7S)-2-Hydroxymethyl- 1-azabicyclo[3.3.0]-octan-3,4,6,7-tetraol monohydrate
C8H15N1O5,H2O
Acta Crystallographica Section E (2004) 60, 9 o1463-o1464
a=7.6230(2)Å b=7.6230(2)Å c=33.8174(10)Å
α=90° β=90° γ=90°
3,7,7a-triepi-Casuarine pentaacetate
C18H25N1O10
Acta Crystallographica Section E (2006) 62, 3 o928-o930
a=9.8357(3)Å b=5.9443(2)Å c=17.2146(6)Å
α=90° β=97.6513(12)° γ=90°
5-Amino-5-deoxy-2-C-hydroxymethyl-2,3-O-isopropylidene-D-talono-1,5-lactam
C10H17N1O6
Acta Crystallographica Section E (2004) 60, 11 o2140-o2141
a=6.1266(2)Å b=6.7254(2)Å c=13.8419(5)Å
α=90° β=99.6456(14)° γ=90°
C17H28O7
C17H28O7
Acta Crystallographica Section E (2006) 62, 9 o3890-o3892
a=6.7757(2)Å b=27.7655(6)Å c=14.8433(3)Å
α=90° β=101.4341(8)° γ=90°
(2<i>R</i>,3<i>S</i>)-3-Hydroxy-<i>N</i>,<i>N</i>-dimethylproline monohydrate
C7H13N1O3,H2O
Acta Crystallographica Section E (2007) 63, 9 o3717-o3717
a=6.0647(2)Å b=7.1798(2)Å c=10.1956(2)Å
α=90° β=109.195(2)° γ=90°
(2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>)-3,4,5-Trihydroxypipecolic acid dihydrate
C6H11N1O5,2(H2O)
Acta Crystallographica Section E (2007) 63, 9 o3783-o3784
a=6.4536(2)Å b=6.7954(2)Å c=20.7965(8)Å
α=90° β=90° γ=90°
1-epi-Alexine hemihydrate
C8H15N1O4,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 12 o649-o652
a=12.4594(6)Å b=7.3115(4)Å c=9.5878(5)Å
α=90° β=93.843(2)° γ=90°
1-epi-Alexine hemihydrate
C8H15N1O4,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 12 o649-o652
a=12.4267(3)Å b=7.30208(18)Å c=9.5708(2)Å
α=90° β=93.839(2)° γ=90°
1-epi-Alexine hemihydrate
C8H15N1O4,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 12 o649-o652
a=12.4190(4)Å b=7.2933(2)Å c=9.5671(3)Å
α=90° β=93.841(3)° γ=90°
1-epi-Alexine hemihydrate
C8H15N1O4,0.5(H2O)
Acta Crystallographica Section C (2008) 64, 12 o649-o652
a=12.4567(5)Å b=7.3097(3)Å c=9.5920(5)Å
α=90° β=93.8151(16)° γ=90°
2,6-Dideoxy-2,6-imino-L-<i>glycero</i>-D-<i>ido</i>-heptitol
C7H15N1O5
Acta Crystallographica Section E (2009) 65, 8 o1755-o1756
a=10.2907(3)Å b=7.6035(3)Å c=11.0057(3)Å
α=90° β=91.8668(16)° γ=90°
[(2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>R</i>)-3,4-dihydroxy-5- (hydroxymethyl)proline]
C6H11N1O5
Acta Crystallographica Section E (2009) 65, 10 o2418-o2419
a=5.4160(2)Å b=5.8236(3)Å c=6.6006(3)Å
α=102.836(2)° β=104.776(2)° γ=102.8244(19)°
Steviamine
C10H20BrN
Acta Crystallographica Section E (2009) 65, 11 o2904-o2905
a=8.46160(10)Å b=8.87620(10)Å c=15.8270(2)Å
α=90° β=90° γ=90°
(3<i>R</i>,4<i>R</i>,5<i>R</i>)-1-(2-carboxyethyl)-3,4-dihydroxy-5- hydroxymethyl-<i>L</i>-proline
C9H15N1O7
Acta Crystallographica Section E (2012) 68, 10 o2865-o2866
a=8.52420(10)Å b=8.57070(10)Å c=14.3585(3)Å
α=90° β=90° γ=90°